Skip to main content

Table 2 Prevalence of Clostridium difficile infections according to age, sex, hospital, hospitalization, HIV status, antibiotic class and corticoid treatment

From: Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon

Variables

Absence of C. difficile n (%) / mean

Presence of C. difficile n (%) / mean

Brute OR

95% CI

P-value

Age

 Age ± SD

33.72 ± 2.3

30.12 ± 3.7

0.99

0.97–1.00

0.11

Sex

 Female

104 (71.7)

41 (28.3)

1

  

 Male

114 (73.5)

41 (26.4)

0.91

0.55–1.52

0,72

Hospital

 CHUY

72 (75.0)

24 (25.0)

1

  

 HCY

50 (67.6)

24 (32.4)

1.44

0.74–2.82

0.29

 HM

35 (66.0)

18 (33.9)

0.89

0.74–3.21

0.25

 HP

34 (80.9)

8 (19.0)

1.54

0.29–1.73

0.45

 HE

27 (77.1)

8 (22.8)

0.71

0.36–2.22

0.80

Hospitalization

 Not

88 (81.5)

20 (18.5)

1

  

 Yes

130 (67.7)

62 (32.2)

2.10

1.18–3.72

0,01

HIV

 Not

139 (70.9)

57 (29.0)

1

  

 Yes

79 (75.9)

25 (24,0)

0.77

0.4–1.33

0.35

Use of penicilline

 Not

204 (72.6)

77 (27.4)

1

  

 Yes

14 (73.7)

5 (26.3)

0.95

0.33–2.72

0.92

Use of cephalosporine

 Not

209 (72.6)

79 (27.4)

1

  

 Yes

9 (75.0)

3 (25.0)

0.88

0.23–3.34

0.85

Use of imidazole

 Not

203 (72.5)

77 (27.5)

1

  

 Yes

15 (75.0)

5 (25.0)

0.88

0.31–2.5

0.81

Use of aminoside

 Not

216 (72.9)

80 (27.0)

1

  

 Yes

2 (50.0)

2 (50.0)

2.7

0.37–19.5

0.33

Use of vancomycine

 Not

216 (73.2)

79 (26.8)

1

  

 Yes

2 (40.0)

3 (60.0)

4.10

0.67–27.0

0.13

Use of quinolone

 Not

209 (72.3)

80 (27.7)

1

  

 Yes

9 (81.8)

2 (18.2)

0.58

0.12–2.75

0.49

Use of corticoids

 Not

214 (72.8)

80 (27.2)

1

  

 Yes

4 (66.66)

2 (0.3)

1.34

0.24–7.45

0.74

  1. CHUY Hospital and University Center, HCY Yaoundé Central Hospita, H Military Hospital, HP Police Hospital, HE Efoulan District Hospital, HIV Human immuno-deficiency virus, CI Confidential interval, OR Odd ratio